Belle Sante Diagnostic And Therapeutic Institute Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 12-12-2024
- Paid Up Capital ₹ 2.00 Cr
as on 12-12-2024
- Company Age 17 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 8.11%
(FY 2021)
- Profit -32.19%
(FY 2021)
- Ebitda -18.00%
(FY 2021)
- Net Worth 18.82%
(FY 2021)
- Total Assets 11.14%
(FY 2021)
About Belle Sante Diagnostic And Therapeutic Institute
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 2.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vinod Haritwal, Vivek Kadambi, and Nilima Kadambi serve as directors at the Company.
- CIN/LLPIN
U85199KA2007PTC043525
- Company No.
043525
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Aug 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Belle Sante Diagnostic And Therapeutic Institute?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vivek Kadambi  | Managing Director | 02-Aug-2007 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vinod Haritwal | Director | 22-Sep-2018 | Current |
| Nilima Kadambi | Director | 02-Aug-2007 | Current |
Financial Performance and Corporate Structure Insights of Belle Sante Diagnostic And Therapeutic Institute.
Belle Sante Diagnostic And Therapeutic Institute Private Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 8.11% increase. The company also saw a substantial fall in profitability, with a 32.19% decrease in profit. The company's net worth Soared by an impressive increase of 18.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Belle Sante Diagnostic And Therapeutic Institute?
In 2021, Belle Sante Diagnostic And Therapeutic Institute had a promoter holding of 0.50% and a public holding of 99.50%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Belle Sante Diagnostic And Therapeutic Institute?
Unlock and access historical data on people associated with Belle Sante Diagnostic And Therapeutic Institute, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Belle Sante Diagnostic And Therapeutic Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Belle Sante Diagnostic And Therapeutic Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
